10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
Medications maintain therapeutic drug levels continuously, whereas food-stimulated GLP-1 secretion occurs in pulses after meals and is rapidly degraded
Hot flashes are a common symptom of menopause, characterized by sudden feelings of heat, sweating, and sometimes redness
This contrasts with the key roles of UV-induced SNVs in melanocytic transformation to early melanoma 4,6
Many Anthem families schedule treatments together